Top part of BME Logo
BME Directory
Middle part of BME Logo Academics Research Directory Student Resources Faculty Resources Visitors
Lola M. Reid
Adjunct Professor, Affiliated Program Faculty

Professor in the Department of Cell and Molecular Physiology
Full Member of the Lineberger Cancer Center
Full Member of the Center for Gastrointestinal and Biliary Disease Biology (CGIBD)


Joint Department of Biomedical Engineering
UNC Chapel Hill and NC State University


UNC Chapel Hill Office
34 Glaxo Bldg
UNC Chapel Hill
Chapel Hill, NC 27599-7038
Phone: 919-966-0346

E-mail: 

Homepage: http://www.med.unc.edu/wrkunits/2depts/physiolo/fac_reid.htm

Primary Research Area:

Biomedical Engineering including Functional Tissue Engineering

Research Interests:

Liver stem cells and lineage biology

Education:

University of North Carolina at Greensboro, 1963-65
University of Heidelberg, Germany, 1965-1966 (Junior Year Abroad)
BA, University of North Carolina at Chapel Hill, 1969
PhD, University of North Carolina at Chapel Hill, 1974
Postdoctoral Studies at the University of California at San Diego, La Jolla, California, 1974-1977 (Mentors: Dr. Gordon Sato and Dr. John Holland)

About Dr. Lola M. Reid:

Lola Reid was a professor in the Department of Molecular Pharmacology and in the Department of Immunology at the Albert Einstein College of Medicine, Bronx, New York, from 1977-1994. She moved to join the faculty at UNC in December, 1994. She has served on numerous editorial boards and grant study sections, has served as a consultant to many companies and for center grants at multiple institutions, and was a consultant to NASA on biological research in space. In 1995, she founded a company, Renaissance Cell Technologies, focused on clinical programs for liver cell therapies and commercial programs making use of liver lineage biology. The company was financed in 1997 by Incara Pharmaceuticals, Research Triangle Park, NC and in 2000 became a wholly owned subsidiary of Incara. In October, 2002, it was purchased by Toucan Capital, Bethesda, Maryland, to become an independent company, Vesta Therapeutics, dedicated to commercial and clinical programs leading to liver cell therapies and bioartificial organs.

Recent Publications:

  1. Jefferson DM Clayton D, Darnell JE, Jr and Reid LM. (1984) Posttranscriptional modulation of gene expression by media conditions in cultured rat hepatocytes. Mol Cell Biol 4:1929-1934. [ Related link ]
  2. Enat R, Jefferson DM, Ruiz-Opazo N, Gatmaitan Z, Leinwand L and Reid LM. (1984) Hepatocyte Proliferation in vitro: Its dependence on the use of serum-free, hormonally defined medium and substrata of extracellular matrix. Proc. Natl.Acad. Sciences USA 81:1411-1415. [ Related link ]
  3. Gatmaitan Z, Jefferson DM, Ruiz-Opazo N, Biempica L, Arias I, Leinwand L, and Reid LM. (1983) Regulation of growth and differentiation of a rat hepatoma cell line by synergistic interactions of hormones and collagenous substrata. J. Cell Biol. 97:1179-1190. [ Related link ]
  4. Reid LM, Minato N, Gresser I, Holland J, Kadish A, and Bloom B. (1981) Influence of anti-mouse interferon on the growth and metastasis of virus persistently infected tumor cells and of human prostatic tumors in athymic nude mice. Proc. Natl. Acad. Sci. USA 78: 1171-1175. [ Related link ]
  5. Minato N, Bloom B, Jones C, Holland J, and Reid LM. (1979) Mechanism of rejection of virus persistently infected tumor cells by athymic nude mice. J. Exp. Med. 149: 1117-1133. [ Related link ]

Date of Last Modification: 7/18/2006

Return To The Directory      Modify Your Directory Entry